The amniocentesis needle market will register a CAGR of almost 4% by 2023

Thursday, February 28, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Feb. 27, 2019 /PRNewswire/ -- About this marketUndergoing the amniocentesis procedure provides certain opportunities

to both the expectant mother and her families. Amniocentesis yields genetic test results with very high accuracy. It can detect neural tube defects and abdominal wall defects in a pregnant woman. Amniocentesis is the only test Mere amino fluid is taken
for testing, which contains the fetus' cells and proteins. In the presence of congenital disorder in the fetus, the parent can opt for termination (abortion) or decide to carry on with the pregnancy. Amniocentesis and CVS can reliably detect serious genetic abnormalities, which otherwise remain undetected with prenatal screening and prenatal genetic testing. This is a major advantage as care and treatment can be started early if results prove positive. Hence, there is an increasing demand for the amniocentesis procedure for prenatal diagnosis, thereby driving market growth. Technavio's analysts have predicted that the amniocentesis needle market will register a CAGR of almost 4% by 2023.Download the full report: https://www.reportbuyer.com/product/5745774 Market OverviewIncrease in pregnancy rateThe teen birth rate in the US is higher than that in many other developed countries such as Canada and the UK. Thus, the increase in pregnancy rates will indirectly result in the rise of prenatal diagnosis through procedures such as amniocentesis, thereby driving the global amniocentesis needle market.Lack of awareness of amniocentesis techniqueThe popularity of prenatal diagnosis and its efficacy in detecting genetic disorders depends, to a large extent, on the awareness and acceptability of available methods. The lack of awareness of the amniocentesis procedure can lead to marginal demand for this technique, thereby restricting market growth.For the detailed list of factors that will drive and challenge the growth of the amniocentesis needle market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Download the full report: https://www.reportbuyer.com/product/5745774 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-amniocentesis-needle-market-will-register-a-cagr-of-almost-4-by-2023-300803140.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store